Generating PDF document

Please, wait a moment

Too much time loading?
Reload the page and try again.

CYTUVA

GIR - Retina Research Group

Download PDF

Contact Information

Basic Information

  • UniversityUniversidad de Valladolid
  • CenterInstitute of Applied Ophthalmobiology (IOBA)
  • DepartmentSurgery, Ophthalmology, Otorhinolaryngology and Physiotherapy
  • Investigation GroupRetina Research Group


Description

The objective of the UVa Retina Research Group is to solve current problems of retinal pathologies that still lack solution:
  • Identify risk factors.
  • Study the pathogenesis.
  • Propose new therapeutic targets in retinal pathologies.

Objectives:
Creation of multidisciplinary clinical work networks that allow the development of translational research projects.
Development and improvement of experimental models (animal models, cell and organotypic cultures) adjusted to early prediction and risk minimization models.
Research focused on the knowledge of the pathogenic processes involved in some retinal pathologies in order to identify new risk biomarkers and new therapeutic targets.
Organization and leadership in the preparation of observational and experimental studies.

RESEACH LINES

• Development of predictive models of risk of proliferative vitreoretinopathy (VRP). Risk biomarkers: Identification of genetic risk factors associated with the development of VRP.
• Biomaterials for Retinal Pigment Epithelium (EPR) transplantation: Search for new biomaterials for the growth and maintenance of EPR cells.
• Advanced therapies: Mesenchymal stem cell transplantation for the treatment of retinal degenerations and optic nerve diseases.
• Retinal healing and repair. Cell death processes: Analysis of the cellular and molecular modifications that occur in inflammatory-based retinal pathologies. Control of cell death processes.
• Biomedical research models: Development of experimental models for research in the field of ophthalmology.
• Deleterious effects of drugs and toxins on the visual system


Other information

Number of researchers:

14

Technological Line(s):

- Health Sciences

Development status:

In research and development phase

Intellectual Property Rights:

Avances en patologías retinianas

Differentiation in the market:

Novedad/calidad

Applicability of technology:

Yes

Additional Information:

RESEARCH:

1. Advanced therapies for retinal and optic nerve diseases:
  • Cell Therapy, Gene Therapy and Tissue Engineering
2. Biomarkers, inflammation and neuroprotection
3. Telephthalmology
4. Safety and toxicity of ophthalmic medical devices
5. Rare, degenerative and hereditary diseases





UNESCO Code:

3201 - Clinical sciences

Other members:

Rosa María Coco Martín
Itziar Fernández Martínez
See more

Iván Fernández Bueno
Girish Kumar Srivastava
María Rosa Sanabria Ruíz-Colmenares

Photos

Videos

Other resources

Ficha Grupo Retina Uva
See / Download resource

Related projects

Preclinical in vivo - IOBA

The University of Valladolid’s Institute of Applied Ophthalmo-Biology (IOBA), in collaboration with the Department of Medicine, Surgery and Veterinary Anatomy of the University of León, offers its services to companies or scientific groups for the... Read more >

Controlled Environment Laboratory (CEL)

In the IOBA’ controlled environment laboratory (CEL), research studies and/or clinical trials are carried out to evaluate the ocular response from the clinical and biochemical point of view to an ocular treatment or to the wearing of contact lenses... Read more >

Specialized training in vision sciences - IOBA

Doctorate in Vision Sciences. Training in research and university teaching aimed at graduates derived from degrees in Biology, Chemistry, Biochemistry, Biotechnology, Pharmacy, Physics, Medicine, Veterinary Medicine, Statistics, the former Compu... Read more >

Chair - Novartis Chair in Retinal Degenerations and Dystrophies (CatNovDDR)

Aims of the ChairThe purpose of the Chair is to deepen the knowledge of the biological bases and the diagnostic and therapeutic means related to retinal degenerative diseases in general, and hereditary diseases in particular.The aim is to improve the... Read more >

This email will be sent to the technology and knowledge transfer office. In your case, it will also be sent to the researcher responsible for the chosen project.
Fields marked with * are mandatory.

I accept the Privacy Policy

CAPTCHA Image

Type the characters shown in the image on the left.

[ Different image ]

Section heading

close
close
close
No products in the cart.